 | Up a level |
Goodwin, Pamela J; Chen, Bingshu E; Gelmon, Karen A; Whelan, Timothy J; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A; Hershman, Dawn L; Mayer, Ingrid A; Hobday, Timothy J; Bliss, Judith M; Rastogi, Priya; Rabaglio-Poretti, Manuela; Thompson, Alastair M; Rea, Daniel W; Stos, Paul M; Shepherd, Lois E; Stambolic, Vuk; Parulekar, Wendy R (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(35), pp. 5356-5362. 10.1200/JCO.23.00296
Goodwin, Pamela J; Chen, Bingshu E; Gelmon, Karen A; Whelan, Timothy J; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A; Hershman, Dawn L; Mayer, Ingrid A; Hobday, Timothy J; Bliss, Judith M; Rastogi, Priya; Rabaglio-Poretti, Manuela; Mukherjee, Som D; Mackey, John R; Abramson, Vandana G; Oja, Conrad; Wesolowski, Robert; Thompson, Alastair M; Rea, Daniel W; ... (2022). Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial. JAMA : the journal of the American Medical Association, 327(20), pp. 1963-1973. American Medical Association 10.1001/jama.2022.6147
Tutt, Andrew N J; Garber, Judy E; Kaufman, Bella; Viale, Giuseppe; Fumagalli, Debora; Rastogi, Priya; Gelber, Richard D; de Azambuja, Evandro; Fielding, Anitra; Balmaña, Judith; Domchek, Susan M; Gelmon, Karen A; Hollingsworth, Simon J; Korde, Larissa A; Linderholm, Barbro; Bandos, Hanna; Senkus, Elżbieta; Suga, Jennifer M; Shao, Zhimin; Pippas, Andrew W; ... (2021). Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. The New England journal of medicine, 384(25), pp. 2394-2405. Massachusetts Medical Society 10.1056/NEJMoa2105215
Drögemöller, Britt I; Wright, Galen E B; Shih, Joanne; Monzon, Jose G; Gelmon, Karen A; Ross, Colin J D; Amstutz, Ursula; Carleton, Bruce C (2019). CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines. Breast cancer research and treatment, 173(3), pp. 521-532. Springer 10.1007/s10549-018-5027-0
Strasser-Weippl, Kathrin; Higgins, Michaela J; Chapman, Judith-Anne; Ingle, James; Sledge, George W; Budd, George T; Ellis, Matthew; Pritchard, Kathleen; Clemons, Mark J; Badovinac-Crnjevic, Tanja; Han, Lei; Gelmon, Karen A; Rabaglio, Manuela; Elliott, Catherine; Shepherd, Lois; Goss, Paul E (2018). Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27. Journal of the National Cancer Institute JNCI, 110(9), pp. 1003-1008. Oxford University Press 10.1093/jnci/djy017
Drögemöller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen E B; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin J D; Gelmon, Karen A; ... (2017). Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. JAMA oncology, 3(11), pp. 1558-1562. American Medical Association 10.1001/jamaoncol.2017.0502
Aminkeng, Folefac; Ross, Colin J D; Rassekh, Shahrad R; Hwang, Soomi; Rieder, Michael J; Bhavsar, Amit P; Smith, Anne; Sanatani, Shubhayan; Gelmon, Karen A; Bernstein, Daniel; Hayden, Michael R; Carleton, Bruce C; Amstutz, Ursula (2016). Recommendations for Genetic Testing to Reduce the Incidence of Anthracycline-induced Cardiotoxicity. British journal of clinical pharmacology, 82(3), pp. 683-695. Wiley-Blackwell 10.1111/bcp.13008
